Biomerica
BMRA
10 hedge funds and large institutions have $179K invested in Biomerica in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
43% more funds holding
Funds holding: 7 → 10 (+3)
8% more capital invested
Capital invested by funds: $165K → $179K (+$14K)
0.01% more ownership
Funds ownership: 0.11% → 0.12% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$28.9K |
| 2 |
MCC
Malaga Cove Capital
Pv Estates,
California
|
+$7.08K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$718 |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$585 |
| 5 |
Morgan Stanley
New York
|
+$246 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.4K |
BMRA Hedge Fund Activity: Q1 2017 in Review
10 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q1 2017, worth a combined $179K — up 8.5% from $165K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BMRA positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Panagora Asset Management, opening a new position worth an estimated $28.9K. The largest seller was Millennium Management, cutting an estimated $16.4K.
- 10 institutional investors held Biomerica (BMRA) as of Q1 2017, up from 7 in Q4 2016.
- Funds reported $179K of Biomerica stock for Q1 2017, up 8.5% quarter-over-quarter.
- 3 funds opened new Biomerica positions in Q1 2017 and 0 closed out, a net change of +3 holders.
- The largest Biomerica buyer in Q1 2017 was Panagora Asset Management, an estimated $28.9K added.
- The largest Biomerica seller in Q1 2017 was Millennium Management, an estimated $16.4K sold.
Based on aggregated 13F filings for Q1 2017.